Literature DB >> 15900568

Image analysis systems for the detection of disseminated breast cancer cells on bone-marrow cytospins.

Sven Becker1, Graziella Becker-Pergola, Tanja Fehm, Robert Emig, Diethelm Wallwiener, Erich-Franz Solomayer.   

Abstract

We assessed the accuracy of automated cell imaging systems when compared to manual evaluation of cytospin slides in determining the presence of cytokeratin-positive, disseminated breast cancer cells in bone marrow aspirates. A total of 298 cytospin slides of bone marrow aspirates were first evaluated by individual screening by one expert immunocytologist. Subsequently, all 298 slides were evaluated by the Automated Cell Imaging System (ACIS) by ChromaVisiontrade mark. Two separate analysis cycles were performed using ACIS. The results of the two ACIS analysis cycles were almost identical: in 293 out of 298 samples (98.3%), identical numbers of disseminated breast cancer cells were detected. In the remaining five samples (1.7%), the result of the two ACIS analysis cycles differed by only one tumor cell. By using the manual technique, 120 cytospin samples were found to be positive. ACIS was able to detect additional tumor cells in 64 cases. Not once did ACIS miss tumor cells when compared to the manual technique. Using ACIS, we were able to determine the bone marrow status of patients with nonmetastatic breast cancer faster, with greater accuracy, and with greater reproducibility than with the manual technique. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 15900568      PMCID: PMC6808033          DOI: 10.1002/jcla.20064

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  16 in total

1.  Bone marrow micrometastases in primary breast cancer: prognostic significance after 6 years' follow-up.

Authors:  J L Mansi; D Easton; U Berger; J C Gazet; H T Ford; D Dearnaley; R C Coombes
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

2.  Time independence of the prognostic impact of tumor cell detection in the bone marrow of primary breast cancer patients.

Authors:  E F Solomayer; I J Diel; G Salanti; M Hahn; C Gollan; F Schütz; G Bastert
Journal:  Clin Cancer Res       Date:  2001-12       Impact factor: 12.531

3.  Reliable and sensitive analysis of occult bone marrow metastases using automated cellular imaging.

Authors:  K D Bauer; J de la Torre-Bueno; I J Diel; D Hawes; W J Decker; C Priddy; B Bossy; S Ludmann; K Yamamoto; A S Masih; F P Espinoza; D S Harrington
Journal:  Clin Cancer Res       Date:  2000-09       Impact factor: 12.531

4.  Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.

Authors:  S Braun; K Pantel; P Müller; W Janni; F Hepp; C R Kentenich; S Gastroph; A Wischnik; T Dimpfl; G Kindermann; G Riethmüller; G Schlimok
Journal:  N Engl J Med       Date:  2000-02-24       Impact factor: 91.245

Review 5.  Detection and clinical importance of micrometastatic disease.

Authors:  K Pantel; R J Cote; O Fodstad
Journal:  J Natl Cancer Inst       Date:  1999-07-07       Impact factor: 13.506

6.  Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells.

Authors:  E Borgen; B Naume; J M Nesland; G Kvalheim; K Beiske; O Fodstad; I Diel; E F Solomayer; P Theocharous; R C Coombes; B M Smith; E Wunder; J P Marolleau; J Garcia; K Pantel
Journal:  Cytotherapy       Date:  1999       Impact factor: 5.414

7.  Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study.

Authors:  J L Mansi; H Gogas; J M Bliss; J C Gazet; U Berger; R C Coombes
Journal:  Lancet       Date:  1999-07-17       Impact factor: 79.321

Review 8.  Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer.

Authors:  I J Diel; R J Cote
Journal:  Cancer Treat Rev       Date:  2000-02       Impact factor: 12.111

Review 9.  [Disseminated melanoma cells in blood and bone marrow. Significance and detection by potential tumor markers].

Authors:  V Waldmann; M Deichmann; A Jäckel
Journal:  Hautarzt       Date:  2001-04       Impact factor: 0.751

10.  Detection of occult bone marrow micrometastases in patients with operable lung carcinoma.

Authors:  R J Cote; E J Beattie; B Chaiwun; S R Shi; J Harvey; S C Chen; A E Sherrod; S Groshen; C R Taylor
Journal:  Ann Surg       Date:  1995-10       Impact factor: 12.969

View more
  3 in total

1.  Endometrial stromal cells and immune cell populations within lymph nodes in a nonhuman primate model of endometriosis.

Authors:  A J Hey-Cunningham; A T Fazleabas; A G Braundmeier; R Markham; I S Fraser; M Berbic
Journal:  Reprod Sci       Date:  2011-05-26       Impact factor: 3.060

2.  Circulating tumor cells measurements in hepatocellular carcinoma.

Authors:  Franck Chiappini
Journal:  Int J Hepatol       Date:  2012-05-28

3.  The role and clinical relevance of disseminated tumor cells in breast cancer.

Authors:  Malgorzata Banys; Natalia Krawczyk; Tanja Fehm
Journal:  Cancers (Basel)       Date:  2014-01-15       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.